GlassScriptPhysician profile
John R West
NPI 1487606117
$10,281.94
in general payments reported to CMS, 2019-2025
33 companies · $1,597 in 2025
The $1,597 reported for 2025 was more than what 84% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,394 · 2020: $1,036 · 2021: $1,314 · 2022: $1,903 · 2023: $1,346 · 2024: $1,691 · 2025: $1,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,633.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,918.94 | 2019-2025 | Skyrizi, Rinvoq |
| Novartis Pharmaceuticals Corporation | $987.36 | 2019-2025 | |
| Janssen Biotech, INC. | $902.81 | 2019-2025 | Tremfya |
| Amgen INC. | $752.85 | 2019-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $715.91 | 2019-2025 | Ilumya, Odomzo, Blu-U |
| Incyte Corporation | $684.51 | 2022-2025 | Opzelura |
| Pfizer INC. | $652.89 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $585.25 | 2019-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $539.36 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $396.28 | 2019-2025 | Cabtreo, Duobrii, Siliq |
| Genzyme Corporation | $392.43 | 2019-2025 | |
| Leo Pharma INC. | $349.97 | 2019-2023 | Adbry |
| Ucb, INC. | $245.15 | 2019-2025 | Bimzelx |
| Genentech USA, INC. | $175.59 | 2019-2024 | Erivedge |
| E.R. Squibb & Sons, L.L.C. | $128.08 | 2024-2025 | Sotyktu |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $113.80 | 2022-2023 | |
| Convatec INC. | $97.03 | 2023 | |
| Allergan, INC. | $94.98 | 2019 | |
| Biofrontera INC. | $71.42 | 2019-2025 | Ameluz |
| Mayne Pharma Commercial LLC | $64.92 | 2019 | |
| Epi Health, LLC | $64.45 | 2020-2022 | |
| Journey Medical Corporation | $55.31 | 2019-2022 | |
| Prugen, INC. Pharmaceuticals | $51.32 | 2020 | |
| Organogenesis INC. | $43.08 | 2022 | |
| Dusa Pharmaceuticals, INC. | $35.33 | 2019 | |
| Almirall LLC | $33.30 | 2021-2025 | Seysara |
| Azurity Pharmaceuticals, INC. | $30.58 | 2025 | Horizant |
| Arcutis Biotherapeutics, INC. | $19.79 | 2024 | Zoryve |
| Verrica Pharmaceuticals INC. | $19.73 | 2025 | Ycanth |
| Dermira, INC. | $17.10 | 2021 | |
| Vyne Pharmaceuticals INC. | $15.33 | 2020 | |
| Mission Pharmacal Company | $14.74 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $12.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.